Your browser doesn't support javascript.
loading
Pan-cancer analysis reveals interleukin-17 family members as biomarkers in the prediction for immune checkpoint inhibitor curative effect.
Han, Xiaying; Ye, Jianxin; Huang, Runzhi; Li, Yongai; Liu, Jianpeng; Meng, Tong; Song, Dianwen.
Afiliação
  • Han X; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Ye J; Department of Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Huang R; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Li Y; Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Liu J; Division of Spine, Department of Orthopedics, Tongji Hospital Affiliated to Tongji University School of Medicine, Shanghai, China.
  • Meng T; Department of Orthopedics, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Song D; Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Front Immunol ; 13: 900273, 2022.
Article em En | MEDLINE | ID: mdl-36159856

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-17 / Neoplasias Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-17 / Neoplasias Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça